Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2024 ▲▼ | Q2 2024 ▲▼ | Change ▲▼ | Q1 2024 ▲▼ | Q2 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Beam Therapeutics Inc.(BEAM) | 2,346,934 | 2,266,934 | -80,000 | $77.54M | $53.11M | 58.01% | -$24.43M |
| Lyell Immunopharma, Inc.(LYEL) | 20,162,332 | 20,162,332 | 0 | $44.96M | $29.24M | 31.93% | -$15.73M |
| Prime Medicine, Inc.(PRME) | 1,792,210 | 1,792,210 | 0 | $12.55M | $9.21M | 10.06% | -$3.33M |